Home Page
18:47:51 EDT Mon 20 Oct 2014
Enter Symbol
or Name
USA
CA



Theratechnologies Inc
Symbol C : TH
Shares Issued 61,010,603
Close 2013-07-10 C$ 0.29
Recent Sedar Documents

Theratechnologies receives patent for tesamorelin use

2013-07-11 08:12 ET - News Release

Mr. Luc Tanguay reports

THERATECHNOLOGIES OBTAINS US PATENT FOR IMPROVING COGNITIVE FUNCTION WITH TESAMORELIN IN PATIENTS SUFFERING FROM MCI

The U.S. Patent and Trademark Office has issued patent No. 8,481,489 entitled, "GH Secretagogues and Uses Thereof," covering a method of improving cognitive function in a subject suffering from mild cognitive impairment through the administration of tesamorelin. The patent will expire in 2024.

"We are glad the USPTO delivered this patent as it enlarges the protection of tesamorelin for use in a potential therapeutic area," stated Luc Tanguay, president and chief executive officer of Theratechnologies Inc.

© 2014 Canjex Publishing Ltd. All rights reserved.